Publications by authors named "David A Qualls"

Claim this Profile
O
Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure.
Mwanasha H Merrill, Robert A Redd, Nicholas Lambert, Paolo F Caimi, Priyanka Pullarkat, David A Qualls

Hemasphere· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.
James T Yoon, Yinglu Zhou, Mariia Mikhaleva, Daniel S Choi, Stacey M Fernandes, David A Qualls

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.
Andrew Looka, David A Qualls, Daniel Matthews, Robert A Redd, Christopher Sakellis

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
David A Qualls, Nicholas Lambert, Paolo F Caimi, Mwanasha Merrill, Priyanka Pullarkat

Blood· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte-activation gene 3 in non-small-cell lung carcinomas: correlations with clinicopathologic features and prognostic significance.
Daniel J Shepherd, Elisabeth S Tabb, Keiko Kunitoki, M Lisa Zhang, Marina Kem, David A Qualls

Mod Pathol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orthotopic heart transplant rejection in association with immunomodulatory therapy for AL amyloidosis: A case series and review of the literature.
David A Qualls, Gregory D Lewis, Vaishali Sanchorawala, Andrew Staron

Am J Transplant· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes.
Zachariah DeFilipp, Fabian M Troschel, David A Qualls, Shuli Li, Martin W Kuklinski

Biol Blood Marrow Transplant· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of interactions between fluorescently-tagged mutant and wild-type SOD1 in intracellular inclusions.
David A Qualls, Keith Crosby, Hilda Brown, David R Borchelt

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Features of wild-type human SOD1 limit interactions with misfolded aggregates of mouse G86R Sod1.
David A Qualls, Mercedes Prudencio, Brittany L T Roberts, Keith Crosby, Hilda Brown

Mol Neurodegener· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis